• Hypertrophic Cardiomyopathy (HCM)
  • Vaccines: 2023 Year in Review
  • Eyecare
  • Urothelial Carcinoma
  • Women's Health
  • Hemophilia
  • Heart Failure
  • Vaccines
  • Neonatal Care
  • Type II Inflammation
  • Substance Use Disorder
  • Gene Therapy
  • Lung Cancer
  • Spinal Muscular Atrophy
  • HIV
  • Post-Acute Care
  • Liver Disease
  • Biologics
  • Asthma
  • Atrial Fibrillation
  • RSV
  • COVID-19
  • Cardiovascular Diseases
  • Prescription Digital Therapeutics
  • Reproductive Health
  • The Improving Patient Access Podcast
  • Blood Cancer
  • Ulcerative Colitis
  • Respiratory Conditions
  • Multiple Sclerosis
  • Digital Health
  • Population Health
  • Sleep Disorders
  • Biosimilars
  • Plaque Psoriasis
  • Leukemia and Lymphoma
  • Oncology
  • Pediatrics
  • Urology
  • Obstetrics-Gynecology & Women's Health
  • Opioids
  • Solid Tumors
  • Autoimmune Diseases
  • Dermatology
  • Diabetes
  • Mental Health

Central hub to monitor 'doctor shopping'


The National Association of Boards of Pharmacy has developed a platform for sharing prescription monitoring programs

NATIONAL REPORTS-With an unrestricted grant from Purdue Pharma, the National Association of Boards of Pharmacy (NABP) has developed PMP InterConnect, a platform for sharing prescription monitoring programs (PMPs) among states. It is expected to reduce prescription drug abuse and "doctor shopping." With the new software, practitioners and law enforcement officials can query multistate PMPs through a central hub.

"Without the NABP InterConnect, a pharmacist or physician would have to identify every state in which a patient had seen another physician or used another pharmacy and make separate queries to each of those states. Such a system is cumbersome and ineffective," says Carmen Catizone, executive director of NABP.

NABP has invested considerable time and resources to develop the technology system, at the request of member boards of pharmacy and state PMP administrators. PMPs in Ohio and Indiana have already begun deploying the platform to select groups of users, who are now able to exchange prescription data between the two participating states.

As of May 2011, 35 states were operating PMPs with the capacity to receive and distribute prescription information about controlled substances to authorized users, according to the U.S. Drug Enforcement Administration. Thirteen states (Alaska, Arkansas, Delaware, Florida, Georgia, Maryland, Montana, Nebraska, New Jersey, Oregon, South Dakota, Washington and Wisconsin), as well as one U.S. territory (Guam), and the District of Columbia have enacted legislation to establish their PMPs, but the programs are not fully operational.

Related Videos
Related Content
© 2024 MJH Life Sciences

All rights reserved.